Rectal Misoprostol

Rectal Misoprostol is a pharmaceutical formulation of the synthetic prostaglandin E1 analog administered via the rectal route to induce uterine contraction, distinguished from other routes of administration by its localized delivery and systemic absorption profile in the context of uterotonic therapy.

50

Publications

2K

Citations

240

Authors

94

Institutions

Publications per year

2017–2026

4

Authors

240

  1. CH
    Charles H. Rodeck

    University College London, United Kingdom

    4 publications · 169 citations

    4

    h-index

  2. HE
    Hazem El‐Refaey

    University College London, United Kingdom

    4 publications · 207 citations

    4

    h-index

  3. HF
    Horace Fletcher

    University of the West Indies System, Jamaica

    3 publications · 102 citations

    3

    h-index

  4. GJ
    G Justus Hofmeyr

    University of the Witwatersrand, South Africa

    3 publications · 175 citations

    3

    h-index

  5. AA
    Anthony A Bamigboye

    University of the Witwatersrand, South Africa

    2 publications · 188 citations

    2

    h-index

1–5 of 240

Venues

  1. 8

    h-index

  2. Obstetrics and Gynecology

    6 publications · 420 citations

    6

    h-index

  3. PubMed

    Repository · 4 publications · 70 citations

    4

    h-index

  4. Acta Obstetricia Et Gynecologica Scandinavica

    4 publications · 242 citations

    4

    h-index

  5. 4

    h-index

1–5